Stem Cell Market Research Reports
Stem cells are undifferentiated cells of most multi-cellular living organisms able to renew themselves and to repair or create new cells of whatever body’s tissue. They are classified into the two principal categories: adult/“somatic” and embryonic stem cells. According to stem cells’ “potency” the following types are distinguished: totipotent, oligopotent, pluripotent, unipotent, multipotent and stem cells. Oncology, bone/cartilage and cardiology therapeutic industries are the main users of stem cells.
In 2010, the world stem cell market exceeded USD 21 billion. It exhibited considerable upturn over the recent several years and is expected to override USD 63 billion in 2015. North America, Europe and the Asia-Pacific are the top regional markets. The market growth is spurred by the rising demand given the enhancing consumers’ interest in the stem cell products. Geron, Advanced Cell Technology and Neuralstem are the dominant players of the worldwide market.
This MarketPublishers’ catalogue contains research reports providing an extensive guide to the stem cell market. The studies include valuable information on the market size and structure; characterize the market dynamics; identify major factors influencing the market. The researches examine the competitive landscape; describe performance of the leading companies, besides offering their detailed profiles. In addition, data on price trends, consumption changes, the most recent industry activities, product launches as well as future market forecasts are available in the research reports.
... are well considered and complicate is ensured for maintaining quality parameters. India is poised to emerge as the largest source for umbilical cord blood ... of international companies are operating in the stem cell banking market of India. “India Stem Cell Banking Market Analysis” research report outlines ...
Apr, 2013 55 pagesHematopoietic Stem Cell Transplantation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for ...
Feb, 2013 58 pages... of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby ... companies with a brief summary followed by a comprehensive listing of regenerative medicine and stem cells deals, as well as contract documents available in the public ...
Feb, 2013 872 pages... , etc. have high penetration rates of stem cell banking ranging from 15% to 30%. Regions such as, US, Europe, China and India have low penetration rates of ... cells from embryos. The report titled ‘Indian Stem Cell Banking Market: Trend and Opportunities (2012-2017)’ provides an in-depth analysis of the Indian ..
Dec, 2012 54 pages... discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Hematopoietic Stem Cell Transplantation pipeline on the basis of route of administration and molecule type. Profiles of late-stage pipeline products featuring sections ...
Aug, 2012 57 pagesThis report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive ... key and niche players such as Advanced Cell Technology, Inc., BD Biosciences, BioTime, Inc., Cell Cure Neurosciences Ltd., Cellartis AB, GE Healthcare, Millipore ...
Jul, 2012 299 pages... the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of the ... the industry that include favourable regulatory environment, high patient population, stem cell application in drug development, rising consumer awareness, a rise in medical ...
Jul, 2012 65 pages... business intelligence provider, has released its latest research, “Translational Regenerative Medicine%-%Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative ... cell research, gene therapy and tissue engineering. The report also includes insights into the late-stage R&D pipeline for regenerative ...
Jun, 2012 95 pages... new technologies that increase the possibility to launch new therapies in the market place. At present, there has been a spur in investments from pharmaceutical ... companies have planned and aligned their objectives to enter the stem cell market in the next 3-5 years, with a few strategic partnerships already ...
Nov, 2011 160 pages... cord injury, blindness, immune system disorders and cardiovascular disease. Stem Cells - The Hype and the Hope 2010-2025 provides an analytical ... benefits in particular: You will receive a comprehensive analysis of the prospects for stem cells from 2010 to 2025, including predicted revenues, growth rates ...
May, 2010 201 pagesWhy the stem cells market will expand - discover its commercial potential What does the future hold for stem cells in medicine? Visiongain's report shows you potential revenues to 2022, assessing data, trends,...
May, 2012 202 pages... themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. As stem cells can be readily grown ... is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic ...
Jan, 2012 155 pagesGLOBAL MARKET WATCH:
Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The...
This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The ... , Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC. Market data and analytics are derived from primary and secondary research. ...
Feb, 2011 566 pages... leading business intelligence provider, has released its latest research “Targeted Therapeutics - Advancement in Gene Therapy and Stem Cell Therapy will Drive ... is detailed for understanding the approval procedure of TT with main focus on gene and stem cell therapy. Major companies dealing in TT are profiled ...
Feb, 2011 100 pages
